NEUROENDOCRINE PROSTATE CANCER (NEPC)
Clinical trials for NEUROENDOCRINE PROSTATE CANCER (NEPC) explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE PROSTATE CANCER (NEPC) trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE PROSTATE CANCER (NEPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an Alzheimer's drug fight prostate cancer?
Disease control Not yet recruitingThis study tests whether memantine hydrochloride, a drug used for Alzheimer's, can help treat advanced prostate cancer that has stopped responding to standard treatments. About 15 men with metastatic castration-resistant prostate cancer will take the drug alongside their usual th…
Matched conditions: NEUROENDOCRINE PROSTATE CANCER (NEPC)
Phase: PHASE2 • Sponsor: Bin Xu • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
New CAR t therapy targets Hard-to-Treat lung cancers in first human trial
Disease control Not yet recruitingThis early-phase study tests a new treatment called ML261 for people with advanced small cell lung cancer or certain neuroendocrine cancers that have stopped responding to standard therapies. ML261 uses a patient's own immune cells, modified to better recognize and attack cancer …
Matched conditions: NEUROENDOCRINE PROSTATE CANCER (NEPC)
Phase: PHASE1 • Sponsor: Moonlight Bio, Inc • Aim: Disease control
Last updated May 15, 2026 11:54 UTC